Docoh
Loading...

UNH Unitedhealth

UnitedHealth Group Incorporated is an American for-profit managed health care company based in Minnetonka, Minnesota. It offers health care products and insurance services. It is the largest healthcare company in the world by revenue, with 2019 revenue of $242.2 billion. UnitedHealthcare revenues comprise 80% of the Group's overall revenue. The company is ranked 7th on the 2020 Fortune 500.

Company profile

Ticker
UNH
Exchange
CEO
David Wichmann
Employees
Incorporated
Location
Fiscal year end
Former names
UNITED HEALTHCARE CORP
SEC CIK
IRS number
411321939

UNH stock data

(
)

Calendar

1 Mar 21
2 Mar 21
31 Dec 21
Quarter (USD)
Dec 20 Sep 20 Jun 20 Mar 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 16.92B 16.92B 16.92B 16.92B 16.92B 16.92B
Cash burn (monthly) 209.67M (positive/no burn) (positive/no burn) (positive/no burn) (positive/no burn) (positive/no burn)
Cash used (since last report) 428.49M n/a n/a n/a n/a n/a
Cash remaining 16.49B n/a n/a n/a n/a n/a
Runway (months of cash) 78.7 n/a n/a n/a n/a n/a

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
22 Feb 21 John F Rex Common Stock Grant Aquire A No No 0 8,699 0 103,622.668
22 Feb 21 John F Rex Common Stock Payment of exercise Dispose F No No 327.64 8,250 2.7M 94,923.668
22 Feb 21 John F Rex Common Stock Grant Aquire A No No 327.64 16,768 5.49M 103,173.668
22 Feb 21 John F Rex NQSO Common Stock Grant Aquire A No No 327.64 40,703 13.34M 40,703
22 Feb 21 Dirk C McMahon Common Stock Grant Aquire A No No 0 8,699 0 80,751.03
22 Feb 21 Dirk C McMahon Common Stock Payment of exercise Dispose F No No 327.64 8,410 2.76M 72,052.03
22 Feb 21 Dirk C McMahon Common Stock Grant Aquire A No No 327.64 18,444 6.04M 80,462.03
22 Feb 21 Dirk C McMahon NQSO Common Stock Grant Aquire A No No 327.64 40,703 13.34M 40,703
22 Feb 21 Stephen J Hemsley Common Stock Payment of exercise Dispose F No No 327.64 13,785 4.52M 977,622.019
22 Feb 21 Stephen J Hemsley Common Stock Grant Aquire A No No 327.64 30,182 9.89M 991,407.019
85.7% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 2289 2136 +7.2%
Opened positions 310 135 +129.6%
Closed positions 157 106 +48.1%
Increased positions 965 927 +4.1%
Reduced positions 784 809 -3.1%
13F shares
Current Prev Q Change
Total value 285.31B 257.69B +10.7%
Total shares 813.48M 817.6M -0.5%
Total puts 6.55M 6.95M -5.9%
Total calls 5.31M 5.52M -3.7%
Total put/call ratio 1.2 1.3 -2.3%
Largest owners
Shares Value Change
Vanguard 79.09M $27.74B -0.9%
BLK Blackrock 71.59M $25.11B -2.2%
FMR 52.57M $18.43B +0.6%
STT State Street 44.23M $15.51B -3.3%
TROW T. Rowe Price 38M $13.32B +5.2%
Capital World Investors 35.19M $12.34B -6.3%
Wellington Management 33.78M $11.85B -1.0%
Capital Research Global Investors 21.96M $7.7B -1.1%
Capital International Investors 17.86M $6.26B -1.1%
Geode Capital Management 14.16M $4.95B +0.5%
Largest transactions
Shares Bought/sold Change
Viking Global Investors 2.79M +2.79M NEW
Capital World Investors 35.19M -2.37M -6.3%
TROW T. Rowe Price 38M +1.88M +5.2%
BLK Blackrock 71.59M -1.63M -2.2%
CS Credit Suisse 2.78M -1.63M -36.9%
STT State Street 44.23M -1.5M -3.3%
JPM JPMorgan Chase & Co. 13.7M -1.34M -8.9%
Dodge & Cox 5.25M -1.31M -19.9%
Epoch Investment Partners 0 -1.2M EXIT
MS Morgan Stanley 7.99M +986.47K +14.1%

Financial report summary

?
Competition
HumanaCVS HealthCigna HoldingCenteneAetnaAnthemPremierCigna
Risks
  • We are subject to risks associated with public health crises, large-scale medical emergencies and pandemics, such as the COVID-19 pandemic, which could have a material adverse effect on our business, results of operations, financial condition and financial performance.
  • If we fail to estimate, price for and manage our medical costs in an effective manner, the profitability of our risk-based products and services could decline and could materially and adversely affect our results of operations, financial position and cash flows.
  • If we fail to maintain properly the integrity or availability of our data or successfully consolidate, integrate, upgrade or expand our existing information systems, or if our technology products do not operate as intended, our business could be materially and adversely affected.
  • If we sustain cyber-attacks or other privacy or data security incidents resulting in security breaches disrupting our operations or resulting in the unintended dissemination of protected personal information or proprietary or confidential information, we could suffer a loss of revenue and increased costs, exposure to significant liability, reputational harm and other serious negative consequences.
  • If we fail to develop and maintain satisfactory relationships with physicians, hospitals and other service providers, our business could be materially and adversely affected.
  • We are routinely subject to various legal actions due to the nature of our business, which could damage our reputation and, if resolved unfavorably, could result in substantial penalties or monetary damages and materially and adversely affect our results of operations, financial position and cash flows.
  • Any failure by us to manage successfully our strategic alliances or complete, manage or integrate acquisitions and other significant strategic transactions or relationships domestically or outside the United States could materially and adversely affect our business, prospects, results of operations, financial position and cash flows.
  • Our sales performance will suffer if we do not adequately attract, retain and provide support to a network of independent producers and consultants.
  • Unfavorable economic conditions could materially and adversely affect our revenues and our results of operations.
  • Our failure to attract, develop, retain, and manage the succession of key employees and executives could adversely affect our business, results of operations and future performance.
  • Our investment portfolio may suffer losses which could adversely affect our results of operations, financial position and cash flows.
  • If the value of our intangible assets is materially impaired, our results of operations, equity and credit ratings could be materially and adversely affected.
  • If we are not able to protect our proprietary rights to our databases, software and related products, our ability to market our knowledge and information-related businesses could be hindered and our results of operations, financial position and cash flows could be materially and adversely affected.
  • Any downgrades in our credit ratings could adversely affect our business, financial condition and results of operations.
  • Risks Related to the Regulation of Our Business
  • Our business activities are highly regulated and new laws or regulations or changes in existing laws or regulations or their enforcement or application could materially and adversely affect our business.
  • As a result of our participation in various government health care programs, both as a payer and as a service provider to payers, we are exposed to additional risks associated with program funding, enrollments, payment adjustments, audits and government investigations which could materially and adversely affect our business, results of operations, financial position and cash flows.
  • Our businesses providing pharmacy care services face regulatory and operational risks and uncertainties which may differ from the risks of our other businesses.
  • If we fail to comply with applicable privacy, security and data laws, regulations and standards, including with respect to third-party service providers utilizing protected personal information on our behalf, our business, reputation, results of operations, financial position and cash flows could be materially and adversely affected.
  • Restrictions on our ability to obtain funds from our regulated subsidiaries could materially and adversely affect our results of operations, financial position and cash flows.
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: absence, accessed, aerospace, aim, alleged, attrition, began, begun, belonging, biggest, bridging, broader, career, CHNG, coaching, compassion, complementary, concierge, curtail, cybersecurity, dannette, deep, defending, diligence, DuPont, easing, empower, empowerment, enterprise, Envoy, ethnicity, extremely, feedback, flat, guided, half, handling, hardship, heard, hiring, inclusion, inclusive, indictment, leader, leadership, Lear, liable, Lockheed, main, Martin, mentorship, metric, missed, mission, modestly, NASDAQ, Nonqualified, online, outreach, pandemic, Patricia, payoff, pipeline, prioritize, privileged, race, redetermination, restored, SCA, script, sense, simplified, situation, skill, skilled, smith, Stewardship, STOCKHOLDER, strive, Supreme, talent, team, telehealth, temporarily, therapeutic, today, transparent, Triple, unified, unprecedented, vaccine, vigorously, virtual, widespread, workforce
Removed: AAA, Addendum, amid, attack, Ballard, budget, build, challenge, charitable, chiropractic, comparative, concluding, conversion, coordinating, corroborate, created, Delaware, demonstrate, deployed, Dorsey, eligibility, Ellen, emerging, endeavoring, epidemiology, excellence, Fidelity, focused, genetic, govern, head, healthy, hospitalization, imposition, improvement, inappropriately, indeterminable, ingredient, Initial, Jr, Letter, likelihood, limiting, marianne, military, MINE, neighborhood, Nelson, operated, organ, originally, par, procurement, put, replaced, retrospectively, revaluation, reward, scale, selling, shareholder, Steven, strategically, subjected, tailored, tenure, transplant, Whitney, Wilson, written